期刊文献+

阿立哌唑与氯氮平对精神分裂症患者生活质量的影响 被引量:16

Effects of aripiprazole and clozapine on life quality of schizophrenics
下载PDF
导出
摘要 目的:比较阿立哌唑、氯氮平对精神分裂症患者生活质量的影响。方法:60例精神分裂症患者随机分为阿立哌唑组(30例)和氯氮平组(30例),治疗8周。应用阳性与阴性症状评定量表(PANSS)、生活质量量表(QOL)对两组治疗前后进行评定。结果:阿立哌唑与氯氮平均能明显改善患者的精神症状和生活质量。在生理、心理领域,社会关系、独立性、环境领域,阿立哌唑明显优于氯氮平。结论:阿立哌唑能改善精神分裂症患者的生活质量,有利于患者重返社会。 Objective: To compare the effects of aripiprazole and clozapine on the life quality of schizophrenics. Method:Sixty schizophrenic patients were randomly divided into aripiprazole group (n=30) and clozapine group (n=30) for eight weeks.Positive and negative syndrome scale (PANSS) and quality of life scale (QOL) were administered before treatment and at the end of 8 week treatment. Results:Both aripiprazole and clozapine group showed psychotic symptoms and life quality improvement in terms of PANSS and QOL,but aripiprazole group improve more than clozapine group in physiological and psychological domain,interpersonal relationship,independence and environment. Conclusion: Aripiprazole can improve life quality of schizophrenic patients and benefit them for returning to society.
出处 《临床精神医学杂志》 2011年第1期47-48,共2页 Journal of Clinical Psychiatry
关键词 阿立哌唑 氯氮平 精神分裂症 生活质量 aripiprazole clozapine schizophrenia quality of life
  • 相关文献

参考文献4

  • 1Orley J, Saxena S, Hennan H. Quality of life and mental illness, reflection form the perspective of the WHO, QOL[ J ]. Br J Psychiatry, 1998,172 : 291.
  • 2Marder SK, Mc Quade RD, Srock E, et al. Aripiprazole in the treatment of schizophrenia:safety and tolerability in short-term,Placbocontrolled trials [ J ]. Schizophr Res,2003,61 : 123-136.
  • 3ChrzanowsKi WK, Marcus RN, Torbeyns A, et al. Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine [ J ]. Psychopharmacololgy ( Berl ), 2006,189 : 259- 266.
  • 4韦程瀚,余利国.阿立哌唑与利培酮对血清催乳素影响对照研究[J].临床精神医学杂志,2008,18(3):190-190. 被引量:9

二级参考文献4

  • 1黄文武,姜德国.抗精神病新药阿立哌唑[J].上海精神医学,2003,15(5):307-308. 被引量:153
  • 2Marder SR,McQuade RD ,Srock E,et al. Aripiprazale in the treatment of schizophrenia: safety end tolerability inshort-term, placbo-controlled trials[J]. Schizophr Res,2003,61:123-136.
  • 3Stahll SM. dopamine system stabilizers, and aripiprazale, and the next generation of antipsychotics, part 1 ," Goldilocks" actions at dopamine receptors[ J ]. Clin Psychiatry ,2001,62:841-842.
  • 4Kane JM, Carsob WH, Saha AR, et al. Efficacy and safety of aripiprazole and haloperidol wersus placebo inpatients with schizophrenia and schizoaffective disorder [ J ]. Clin Psychiatry, 2002,63 : 763.

共引文献8

同被引文献174

引证文献16

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部